Amitriptyline delayed gastric emptying

Transcription

1 Amitriptyline delayed gastric emptying We have given this statement a conditional recommendation, as the quality of evidence is very low. The data mainly relate to national databases of upper GI cancer risk (28, 29), case series on early gastric cancer detection (23) and economic modeling (27). These types of data are indirect and often overestimate the benefit of endoscopy, so clinicians may treat a minority of patients over the age of 60 with empirical therapy provided they feel the risk of upper GI cancer malignancy is low. On the other hand, the risk of upper GI malignancy increases in those who were born and spent their TEENhood in certain geographical regions such as South East Asia and some countries in South America (31). In light of the conditional recommendation with the quality of evidence being low, the age threshold for endoscopy should be lowered in these patients, and possibly others, according to clinical judgment. In borderline cases the sex of the patient may be taken into consideration as age-adjusted upper GI cancer risk is about twice as high in men as it is in women (31). As with all guidelines, clinical decisions should be based on symptoms, patient concerns, physical examination findings, laboratory and radiologic studies, and data from the literature, when available. Intravenous fluids to correct dehydration and replenish electrolytes if nutrition is adequate but symptoms occasionally interrupt the intake of even liquid food. Enteral nutrition which provides liquid food directly into the small intestine, bypassing the paralyzed stomach. Intravenous total parenteral nutrition (TPN) to provide calories and nutrients (TPN is a fluid containing glucose, amino acids, lipids, minerals, and vitamins -everything that is needed for adequate nutrition-intravenously. The fluid usually is delivered into a large vein via a catheter in the arm or upper chest.) Doctors generally prefer enteral nutrition over TPN because long-term use of TPN is associated with infections of the catheter and liver damage. Infection can spread through the blood to the rest of the body, a serious condition called sepsis. Catheter-related sepsis often requires treatment with intravenous antibiotics and removal of the infected catheter or replacement with a new catheter. TPN also can damage the liver, most commonly

2 catheter. TPN also can damage the liver, most commonly causing abnormal liver tests in the blood. TPN-induced liver damage usually is mild and reversible (the liver test abnormalities return to normal after cessation of TPN), but, rarely, irreversible liver failure can occur. Such liver failure may require liver transplantation. Abdominal bloating (upper abdomen feels or actually looks distended, tight after eating). Our ultimate goal is to help your TEEN live as healthy, active and comfortable a life as possible. Applying to GI Fellowship Programs: What You Need to Know. Early satiety (feeling full after only a few bites of food, inability to finish meals). The goals of nutritional management are to ensure adequate calories, and that nutrients are consumed to promote your TEEN's growth and development. Maintaining a healthy diet can help control the symptoms of gastroparesis. Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars- Sinai Medical Center in Los Angeles. Unfortunately, at this time, there is lack of national standardization of test protocol for pediatric patients. Techniques vary in hospitals regarding size or volume of the test meal used, patient positioning, frequency and duration of monitoring. Click Join ACG to access applications and information on ACG Member categories. In patients with refractory symptoms of GERD, investigation for delayed gastric emptying should be considered, since delayed gastric emptying can be associated with GERD and possibly aggravate symptoms of heartburn, regurgitation, and other symptoms associated with GERD. In TEENren, gastroparesis may be an acute primary self-limiting disorder triggered by infection, surgery or excessive weight loss. More commonly, however, pediatric gastroparesis overlaps in an individual patient with other chronic GI motility disorders including: Most published literature describes gastroparesis as delayed gastric emptying without a mechanical obstruction. Entrustable Professional Activities (EPAs) for GI Fellowship Training. Please call the Communications Team at or e- mail. Cisapride is a gastrointestinal, prokinetic agent that increases motility in the gastrointestinal tract by increasing the excitability of the esophagus, small intestine and colon. In comparison, metoclopramide acts only on the small intestine. Cisapride is regulated by the FDA and is only available at select highly specialized institutions. A risk of cisapride is serious cardiac arrhythmias, and for this reason the medication can only be prescribed and dispensed by participating providers to ensure careful monitoring. Patients must meet very strict eligibility criteria and be willing to follow the treatment schedule in order to participate. home / diabetes health center / diabetes a-z list / gastroparesis center. Dietary changes are tailored to each patient and may include:. What drugs relieve pain and nausea from gastroparesis?. Authored by a talented group of GI experts, the College is devoted to the development of new ACG guidelines on gastrointestinal and liver diseases. Our guidelines reflect the current state-of-the-art scientific work and are based on the principles of evidence-based medicine.

3 and are based on the principles of evidence-based medicine. ACG welcomes inquiries about digestive health from the media and can make experts available for interviews upon request. Surgery: Surgery occasionally is used to treat gastroparesis. The goal of surgery is to create a larger opening between the stomac Symptoms of gastroparesis mirror some symptoms of delayed gastric emptying and include:. Patients were randomized to a placebo, 10 mg escitalopram, or 25 mg amitriptyline during a 2-week run-in phase, followed by 50 mg amitriptyline for a total of 12 weeks. They were evaluated at baseline with gastric-emptying tests, nutrient drink tests, and blood draws; a subset of patients also underwent evaluation of gastric accommodation by single-photon emission computed tomography. The SSRI (selective serotonin re-uptake inhibitors) group of antidepressants is generally avoided for use in functional and motility gut disorders, primarily due to their high incidence of side effects of nausea, dizziness and dry mouth as well as sexual dysfunction. Data source: A prospective, randomized, double-blind double-dummy study of 292 patients with functional dyspepsia. Entrustable Professional Activities (EPAs) for GI Fellowship Training. Disclaimer: GPDA's Web site is intended for educational and informational purposes only. Any suggestions provided on the GPDA Web site should never be undertaken without your health care professional's knowledge and guidance. If you have a digestive problem, seek professional care The Gastroparesis & Dysmotilities Association. therapy; this may improve symptoms and the delayed gastric. Journalists access information on digestive health, including the latest ACG news and up-to-date information about ACG's Annual Scientific Meeting and the latest clinical science. Diabetic (29%), postsurgical (13%), and idiopathic (36%) etiologies comprise the majority of cases in tertiary referral setting (8). Diabetes mellitus is the most commonly recognized systemic disease associated with gastroparesis. In the NIH consortium cohort, delayed gastric emptying was more pronounced in patients with type 1 DG (10). The 10-year incidence of gastroparesis has been reported to be 5.2% in type 1 diabetes, 1% in type 2 diabetes, and 0.2% in non-diabetic controls in a US community (5). like peptide-1 (GLP-1) and amylin analogs among diabetics,. Serious ( 1) or very serious ( 2) limitation to study quality. Idiopathic gastroparesis refers to a symptomatic patient from delayed gastric empting with no detectable primary underlying abnormality for the delayed gastric emptying. This may represent the most common form of gastroparesis (10,17). Most patients with IG are women; typically young or middle aged. Symptoms of IG overlap with those of functional dyspepsia; it may be difficult to provide a definitive distinction between the two based on symptoms, and many regard IG and functional dyspepsia with delayed gastric emptying as the same condition. Abdominal pain/discomfort typically is the predominant symptom in functional dyspepsia, whereas nausea, vomiting, early satiety, and bloating predominate in IG. Therefore, measurement of gastric emptying is important, as therapies differ if gastric emptying is delayed, normal, or rapid.

4 therapies differ if gastric emptying is delayed, normal, or rapid. etiological diagnosis. Narcotics and other medications that can. Some ( 1) or major ( 2) uncertainty about directness. Authored by a talented group of GI experts, the College is devoted to the development of new ACG guidelines on gastrointestinal and liver diseases. Our guidelines reflect the current state-of-the-art scientific work and are based on the principles of evidence-based medicine. We comply with the HONcode standard for trustworthy health information: verify here. From articles to educational programs, ACG provides you tools and techniques you can use in your practice that will help improve efficiency and increase profitability. Learn from experts at ACG's live and web-based educational programs, read what others are doing in their practice to solve problems they encounter and connect with colleagues online to discuss important issues and share ways to improve practice. ACG GI Circle, Hepatology Circle, ACG & CCF IBD Circle and Functional GI Health and Nutrition Circle. delay gastric emptying should be stopped to establish the diagnosis. Keep up with the latest news and developments on Capitol Hill, CMS and the FDA. ACG has compiled a wealth of resources to help keep members up-to-date on the latest legislative and regulatory actions that impact the gastroenterology practice, as well as tools to help you manage your practice in light of these changes and take action on important issues. You can make a difference. From health care reform to other legislative and regulatory issues that affect your practice; every voice counts. Intro / Digestion / Who gets GP / What happens / Symptoms / Dx / Mild forms / Tx. 1 Department of Gastroenterology, Mayo Clinic, Rochester, Minnesota, USA; 2 Temple University, Philadelphia, Pennsylvania, USA; 3 University of Texas, MD Anderson Cancer Center, Houston, Texas, USA; 4 University of Mississippi, Jackson, Mississippi, USA; 5 Stanford University, Palo Alto, California, USA. chemotherapy patients such as aprepitant ( Emend ), and medical marijuana ( Marinol ). Gastroparesis can be caused either by diseases of the stomach's muscles or the nerves that control the muscles, though often no specific cause is identified. The most common disease causing gastroparesis is diabetes mellitus, which damages the nerves controlling the stomach muscles. Gastroparesis also can result from damage to the vagus nerve, the nerve that controls the stomach's muscles, that occurs during surgery on the esophagus and stomach. Scleroderma is an example of a disease in which gastroparesis is due to damage to the stomach's muscles. Occasionally, gastroparesis is caused by reflexes within the nervous system, for example, when the pancreas is inflamed ( pancreatitis ). In such cases, neither the nerves nor the muscles of the stomach are diseased, but messages are sent through nerves from the pancreas to the stomach, which prevents the muscles from working normally. Other causes of gastroparesis include imbalances of minerals in the blood such as potassium, calcium or magnesium, medications (such as narcotic pain - relievers), and thyroid disease. For a substantial number of patients no cause can be found for the gastroparesis, a

5 patients no cause can be found for the gastroparesis, a condition termed idiopathic gastroparesis. Indeed, idiopathic gastroparesis is the second most frequent cause of gastroparesis after diabetes. Gastroparesis can occur as an isolated problem or it can be associated with weakness of the muscles of other parts of the intestine, including the small intestine, colon, and esophagus. home / diabetes health center / diabetes a-z list / gastroparesis center. Surgery: Surgery occasionally is used to treat gastroparesis. The goal of surgery is to create a larger opening between the stomac Treatment of gastroparesis includes diet, medication, and devices or procedures that facilitate emptying of the stomach. The goals of treatment include: Gastroparesis is a disease of the muscles of the stomach or the nerves controlling the muscles that causes the muscles to stop working. Gastroparesis results in inadequate grinding of food by the stomach, and poor emptying of food from the stomach into the intestine. The primary symptoms of gastroparesis are nausea, vomiting, and abdominal pain. Gastroparesis is best diagnosed by a test called a gastric emptying study. Gastroparesis usually is treated with nutritional support, drugs for treating nausea and vomiting, drugs that stimulate the muscle to work, and, less often, electrical pacing, and surgery. To provide a diet containing foods that are more easily emptied from the stomach. Controlling underlying conditions that may be aggravating gastroparesis. Relieve symptoms of nausea, vomiting, and abdominal pain. Stimulate muscle activity in the stomach so that food is properly ground and emptied from the stomach Maintaining adequate nutrition. What drugs relieve pain and nausea from gastroparesis?. How Is Your MS Care Routine? Assess Yourself. What is the treatment for gastroparesis and its symptoms?. What is the treatment for gastroparesis and its symptoms?. What drugs relieve pain and nausea from gastroparesis?. What is the prognosis (long-term outcome) for patients with gastroparesis?. MedicineNet does not provide medical advice, diagnosis or treatment. See additional information. What is the prognosis (long-term outcome) for patients with gastroparesis?. Intravenous fluids to correct dehydration and replenish electrolytes if nutrition is adequate but symptoms occasionally interrupt the intake of even liquid food. Enteral nutrition which provides liquid food directly into the small intestine, bypassing the paralyzed stomach. Intravenous total parenteral nutrition (TPN) to provide calories and nutrients (TPN is a fluid containing glucose, amino acids, lipids, minerals, and vitamins -everything that is needed for adequate nutrition-intravenously. The fluid usually is delivered into a large vein via a catheter in the arm or upper chest.) Doctors generally prefer enteral nutrition over TPN because long-term use of TPN is associated with infections of the catheter and liver damage. Infection can spread through the blood to the rest of the body, a serious condition called sepsis. Catheter-related sepsis often requires treatment with intravenous antibiotics and removal of the infected catheter or replacement with a new catheter. TPN also can damage the liver, most commonly causing abnormal liver tests in the blood.

6 liver, most commonly causing abnormal liver tests in the blood. TPN-induced liver damage usually is mild and reversible (the liver test abnormalities return to normal after cessation of TPN), but, rarely, irreversible liver failure can occur. Such liver failure may require liver transplantation. Drugs used to relieve abdominal pain in gastroparesis include nonsteroidal antiinflammatory drugs ( NSAIDs ) such as ibuprofen ( Motrin ) and naproxen ( Aleve ), low dose tricyclic antidepressants such as amitriptyline ( Elavil, Endep ), drugs that block nerves that sense pain such as gabapentin ( Neurontin ), and narcotics such as tramadol ( Ultram ) and fentanyl ( Duragesic ). (Nevertheless, narcotics as a group tend to cause constipation and slow emptying of the stomach, and, therefore, should be avoided or used with caution in patients with gastroparesis. Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles. Oral Drugs: There are four oral drugs that are used to stimulate contractions of the stomach's muscles, referred to as pro-motility drugs. These drugs are 1) cisapride ( Propulsid ), 2) domperidone, 3) metoclopramide ( Reglan ), and 4) erythromycin. Cisapride (Propulsid) is an effective drug for treating gastroparesis; however, it was removed from the market because it can cause serious and life-threatening irregular heart rhythms. Despite this fact, it can be obtained for use through the pharmaceutical company that manufactures it (Janssen Pharmaceuticals) under a strictly monitored protocol but only for patients with severe gastroparesis unresponsive to all other measures. Domperidone has not been released for use in the US; however, it too can be obtained if approval is obtained for its use from the US Food and Drug Administration. Metoclopramide (Reglan) is available without restriction and is effective at promoting muscular activity in the stomach; however, there are side effects of metoclopramide that can limit its use. Erythromycin (E-Mycin, Ilosone, etc.), is a uncommonly used antibiotic. At doses lower than those used to treat infections, erythromycin stimulates contractions of the muscles of the stomach and small intestine and is useful for treating gastroparesis. It has been demonstrated that tegaserod ( Zelnorm ), an oral drug used for treating constipation in irritable bowel syndrome ( IBS ), increases emptying from the stomach just as it does from the colon. However, in March of 2007, the FDA asked Novartis to suspend sales of tegaserod ) in the United States because a retrospective analysis of data by Novartis from more than 18,000 patients showed a slight difference in the incidence of cardiovascular events ( heart attacks, strokes, and angina ) among patients on tegaserod compared to placebo. The data showed that cardiovascular events occurred in 13 out of 11,614 patients treated with tegaserod (0.1%), compared to one cardiovascular event in 7,031 (0.01%) placebo-treated patients. However, it is unclear whether tegaserod actually causes heart attacks and strokes. Despite this fact, the availability of tegaserod in the U.S. is limited to emergency situations. There are two important

7 limited to emergency situations. There are two important guidelines in prescribing oral drugs for gastroparesis. First, the drugs must be given at the right times, and second, the drugs must reach the small intestine so that they can be absorbed into the body. Since the goal of treatment is to stimulate muscular contractions during and immediately after a meal, drugs that stimulate contractions should be given before meals. Most drugs must be emptied from the stomach so that they can be absorbed in the small intestine. The majority of patients with gastroparesis have delayed emptying of solid food as well as pills and capsules. As mentioned previously, many patients with gastroparesis have less of a problem emptying liquids as compared with solid food. Therefore, liquid medications usually are more effective than pills or capsules. Intravenous drugs Occasionally, patients have such poor emptying of both liquid and solid food from the stomach that only drugs given intravenously are effective. In such patients, intravenous metoclopramide or erythromycin can be used. A third option is octreotide ( Sandostatin ), a hormone-like drug that can be inj. Diet Emptying from the stomach is faster when there is less food to empty, so smaller, more frequent portions of food are recommended. Soft foods (or preferably liquid) that do not require grinding also are emptied more easily. Moreover, in gastroparesis, the emptying of liquids often is less severely affected than the emptying of solids. Fat causes the release of hormones that slow down the emptying of the stomach. Therefore, foods low in fat empty faster from the stomach. In patients with severe gastroparesis, sometimes only liquid meals are tolerated. It also is recommended that the diet be low in fiber (for example, vegetables) due to the concern about the formation of bezoars, and the fact that fiber slows gastric emptying - at least in normal individuals. Food should be chewed well since the grinding action of the stomach is reduced. Meals should be taken with enough liquids to ensure maximal liquidity of contents in the stomach since liquids usually empty better than solid food; however, if liquid emptying also is slow, too much liquid might create problems. (Only trial and error will determine the effects of increased liquids.) Patients with gastroparesis should have most food early in the day, especially the solid food; they should not lie down for 4-5 hours after their last meal, since when lying, the assistance of gravity on gastric emptying is lost. Multivitamins should be taken because of the likelihood of malnutrition and vitamin and mineral deficiencies.

8